Biliopancreatic Diversion Shows Durable Weight Loss but High Long-Term Morbidity

Lifelong physiological implications of hypoabsorptive bariatric interventions

Bariatric surgery remains the most effective clinical intervention for achieving sustained weight loss and the remission of metabolic comorbidities in patients with severe obesity [1, 2, 3, 4]. While Roux-en-Y gastric bypass and sleeve gastrectomy are widely utilized, hypoabsorptive techniques like biliopancreatic diversion often result in greater weight reduction, with meta-analytic data showing a 7.31 kg/m² higher loss in body mass index compared to gastric bypass [5, 6]. However, these profound physiological alterations carry a significant risk of chronic micronutrient deficiencies, including zinc deficiency in 26.1% of patients alongside the depletion of copper and fat-soluble vitamins [7, 8, 5]. Despite established mid-term efficacy, clinical data regarding safety and all-cause mortality beyond the second postoperative decade remain scarce, although the Swedish Obese Subjects trial reported an adjusted hazard ratio of 0.71 for overall mortality at 20 years [9, 10]. To address this knowledge gap, researchers now provide a 50-year perspective on the original cohort of 85 patients who underwent biliopancreatic diversion, offering critical insights into the lifelong consequences of surgically induced malabsorption [9].

Cohort characteristics and longitudinal study design

The researchers conducted a retrospective analysis of a prospectively maintained database, a rigorous design that captures clinical events in real time to minimize recall bias while allowing for long-term historical review. This approach enabled the continuous tracking of the first 85 consecutive patients who underwent the original biliopancreatic diversion procedure between 1976 and 1979. By following this specific group from the inception of the technique, the study offers clinicians an unprecedented longitudinal window into the physiological consequences of malabsorptive surgery over five decades. The initial cohort was predominantly female, consisting of 70 females and 15 males. At the time of their index surgery, the participants had a mean preoperative age of 35 years, representing a relatively young patient population with decades of life expectancy ahead. The baseline severity of their condition was marked by a mean preoperative body mass index of 42.2 kg/m². For the practicing clinician, these baseline characteristics are essential for contextualizing the subsequent rates of nutritional complications and mortality, as they represent the physiological foundation upon which a lifetime of surgical malabsorption was superimposed.

Universal metabolic remission and sustained weight reduction

The efficacy of biliopancreatic diversion in achieving substantial and lasting weight reduction is clearly evidenced by the longitudinal tracking of the cohort over half a century. The researchers observed that the percent total weight loss was 31% at 1 year following the procedure. Unlike many restrictive bariatric interventions where weight regain is a common clinical challenge in the second decade, this cohort demonstrated a continued downward trend or stabilization of weight over the long term. Specifically, the percent total weight loss increased to 39% at more than 40 years postoperatively. This indicates that the profound malabsorptive nature of the procedure maintains a physiological state conducive to weight maintenance even four decades after the initial surgical intervention. Beyond weight loss, the metabolic impact of the procedure on glucose homeostasis was striking. The study found that remission of type 2 diabetes was universal and durable throughout the entire follow-up period. For clinicians managing patients with severe obesity and comorbid metabolic dysfunction, this highlights the sheer potency of biliopancreatic diversion in resolving insulin resistance and hyperglycemia. Every patient in the cohort who presented with type 2 diabetes at baseline achieved clinical remission, and this state was maintained without relapse for the duration of their lives or the 50-year study window.

Long-term survival and mortality compared to general populations

The longitudinal data reveal a significant mortality burden among patients who underwent biliopancreatic diversion. The researchers reported that all-cause mortality over the 50-year follow-up period was 29.4% (25 deaths out of the original 85 patients). To visualize patient survival over time, the authors utilized Kaplan-Meier survival estimates, a statistical method that calculates the probability of surviving past specific time intervals. These estimates showed a high initial survival rate of 98.8% at 1 year, which gradually declined to 89.1% at 10 years and 80.7% at 20 years. As the cohort entered the third and fourth decades post-surgery, survival estimates continued to drop, reaching 67.8% at 30 years and 53.7% at 40 years. To contextualize these findings, the researchers compared the cohort's mortality against the Italian general population using national life tables. This analysis yielded a standardized mortality ratio of 2.62 (95% CI 1.71-3.86), indicating that the risk of death in the operated cohort was more than double what would be expected in the age-matched general population. Crucially, despite the profound weight loss and metabolic improvements, the mortality in the operated cohort was similar to that of a historical cohort of non-operated severely obese Italians. For the practicing physician, this is a sobering finding: while biliopancreatic diversion effectively manages weight and diabetes, it does not appear to provide a long-term survival advantage over untreated severe obesity, likely due to the high incidence of late-stage nutritional and surgical complications.

Progressive nutritional morbidity and late surgical revisions

The metabolic benefits of biliopancreatic diversion are accompanied by a substantial and progressive burden of nutritional deficiency that evolves over decades. While the prevalence of any nutritional complication was 13% at 1 year postoperatively, this figure rose dramatically as the cohort aged. By the time patients reached more than 40 years postoperatively, the prevalence of any nutritional complication increased to 86%. This nearly universal rate of morbidity suggests that the hypoabsorptive state (a condition where the surgically bypassed small intestine significantly limits the absorption of calories, proteins, and essential micronutrients) creates a lifelong physiological challenge that intensifies rather than stabilizes over time. The severity of these nutritional and gastrointestinal issues often necessitated further operative intervention long after the initial weight loss phase. The researchers reported that the surgical revision rate for malnutrition or diarrhea was 20% (17 out of the 85 patients). These were not merely early complications of the surgical technique; revision procedures for malnutrition or diarrhea occurred up to 26 years postoperatively. For clinicians, these findings underscore the absolute necessity of permanent, vigilant follow-up. The risk of severe, life-altering complications requiring surgical correction remains a persistent threat for more than a quarter-century after the index procedure, demonstrating that the metabolic advantages of extreme malabsorptive surgery are inextricably linked to a high risk of chronic nutritional morbidity.

References

1. Gloy V, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013. doi:10.1136/bmj.f5934

2. Wiggins T, Guidozzi N, Welbourn R, Ahmed AR, Markar SR. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis. PLoS Medicine. 2020. doi:10.1371/journal.pmed.1003206

3. Yumuk V, Tsigos C, Fried M, et al. European Guidelines for Obesity Management in Adults. Obesity Facts. 2015. doi:10.1159/000442721

4. Maggard MA, Shugarman LR, Suttorp MJ, et al. Meta-Analysis: Surgical Treatment of Obesity. Annals of Internal Medicine. 2005. doi:10.7326/0003-4819-142-7-200504050-00013

5. Salte OBK, Olbers T, Risstad H, et al. Ten-Year Outcomes Following Roux-en-Y Gastric Bypass vs Duodenal Switch for High Body Mass Index: A Randomized Clinical Trial.. JAMA network open. 2024. doi:10.1001/jamanetworkopen.2024.14340

6. Esparham A, Roohi S, Mehri A, Ghahramani A, Moghadam HA, Khorgami Z. Roux-en-Y gastric bypass versus duodenal switch in patients with body mass index ≥50 kg/m²: a systematic review and meta-analysis.. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2025. doi:10.1016/j.soard.2024.08.042

7. Jiao Y, Liu Y, Chen S, Tang L. Zinc Deficiency After Bariatric Surgery: A Systematic Review and Meta-analysis. Indian Journal of Surgery. 2024. doi:10.1007/s12262-024-04082-1

8. Haughton S, Gentry S, Parretti HM. Nutritional Deficiencies Following Bariatric Surgery: A Rapid Systematic Review of Case Reports of Vitamin and Micronutrient Deficiencies Presenting More Than Two Years Post-Surgery.. Clinical obesity. 2025. doi:10.1111/cob.70035

9. Papadia FS, Adami GF, Roscelli C, Cassano M, Cian OD. Biliopancreatic Diversion for Severe Obesity: A 50-Year Cohort Study on Survival, Weight Loss, Control of Metabolic Comorbidities, Nutritional Morbidity, and Late Revisions.. Annals of surgery. 2026. doi:10.1097/SLA.0000000000007087

10. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. Journal of Internal Medicine. 2013. doi:10.1111/joim.12012